CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 140 filers reported holding CLOVIS ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,960,000 | -41.8% | 75,000 | -25.0% | 0.80% | -49.8% |
| Q4 2017 | $6,800,000 | -75.9% | 100,000 | -66.8% | 1.60% | -72.8% |
| Q2 2017 | $28,183,000 | +121.3% | 301,000 | +50.5% | 5.86% | +146.9% |
| Q1 2017 | $12,734,000 | +30.3% | 200,000 | -9.1% | 2.37% | +0.9% |
| Q4 2016 | $9,772,000 | -45.8% | 220,000 | -56.0% | 2.35% | -19.5% |
| Q3 2016 | $18,025,000 | +38.3% | 500,000 | -47.4% | 2.92% | -22.3% |
| Q2 2016 | $13,034,000 | +3571.5% | 950,000 | +5035.1% | 3.76% | +1772.6% |
| Q1 2016 | $355,000 | -79.7% | 18,500 | -63.0% | 0.20% | -72.0% |
| Q4 2015 | $1,750,000 | -40.6% | 50,000 | -23.1% | 0.72% | -55.2% |
| Q3 2014 | $2,948,000 | +63.1% | 65,000 | +116.7% | 1.60% | +43.9% |
| Q4 2013 | $1,808,000 | – | 30,000 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |